Skip to main content

Conference Insider

First Report Managed Care
A chronic disease’s estimated annual cost varies depending on the method used to arrive at the calculation, with inconsistent differences across diseases.
First Report Managed Care
“Asthma continues to be a disease with significant burden in the United States, and economic impact is significantly associated with asthma severity,” researchers wrote.
First Report Managed Care
Researchers recently advised that a unique criterion and process must be used to evaluate drugs for placement in a value-based formulary.
First Report Managed Care
Researchers presented data at AMCP 2021 on the effectiveness of physician follow-up phone calls compared to letters in an effort to reduce drug-related problems and unnecessary pharmacy drug spend for health plans.
First Report Managed Care
“Although increases in utilization and cost to the plan were observed for many policies deemed appropriately archived, it was determined that the clinical benefits and the reduction in provider, member, and administrative burden offset the increases in cost to the plan,” wrote researchers at AMCP…
First Report Managed Care
According to research presented at AMCP 2021, although there is interest in expanding support offerings in the future, current care management and disease state education remain the mainstays of support among health care stakeholders for patients with orphan diseases.
First Report Managed Care
“This trend implies a significant opportunity to adopt greater pharmacogenomics testing to improve the benefit of medications in patients and reduce potential risks,” said researchers.
First Report Managed Care
According to data presented at AMCP 2021, there is evident variability among commercial health plans and their applied prescriber requirements—which can create access barriers for patients, especially those in need of specialty drugs.
First Report Managed Care
Research findings presented at AMCP 2021 suggest that differences in patient-reported outcomes between authorized and independent generics were small and varied by therapeutic area, and market factors may be key in shaping observable switching patterns.
First Report Managed Care
“Educational interventions with instructive information in a written format can provide additional insight to address the barriers to adherence,” researchers wrote.
Back to Top